Update on medication-overuse headache

Current Pain and Headache Reports

Volumn 15, Issue 1, 2011, Pages 79-83

  De Felice, Milena ^a   Ossipov, Michael H ^a   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Medication overuse headache; Migraine; Neuroadaptive changes; Opiates; Triptans

Indexed keywords

ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; MORPHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NXN 323; OPIATE DERIVATIVE; PARACETAMOL; SUMATRIPTAN; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIA; ARTICLE; BEHAVIOR THEORY; COMORBIDITY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG INDUCED HEADACHE; FACILITATION; HUMAN; HYPERALGESIA; MENTAL DISEASE; MIGRAINE; NERVE CELL PLASTICITY; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; RISK FACTOR; SENSORY NERVE; SUBSTANCE ABUSE; TRIGEMINAL NERVE;

ANALGESICS; HEADACHE DISORDERS, SECONDARY; HUMANS; MIGRAINE DISORDERS; TRYPTAMINES;

EID: 79551516452     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-010-0155-1     Document Type: Article

References (44)

1. SD Silberstein J Olesen MG Bousser, et al. 2005 The International Classification of Headache Disorders, 2nd Edition (ICHD-II): revision of criteria for 8.2 Medication-overuse headache Cephalalgia 25 460 465 1:STN:280:DC%2BD2M3mvVGiug%3D%3D 15910572 Published erratum appears in Cephalalgia 2006, 26:360
2. Fritsche G, Frettloh J, Huppe M, et al.: Prevention of medication overuse in patients with migraine. Pain 2010 Aug 26 (Epub ahead of print).
3. P Calabresi LM Cupini 2005 Medication-overuse headache: similarities with drug addiction Trends Pharmacol Sci 26 62 68 1:CAS:528:DC%2BD2MXoslahtQ%3D%3D 15681022
4. JL Fuh SJ Wang SR Lu KD Juang 2005 Does medication overuse headache represent a behavior of dependence? Pain 119 49 55 16298069
5. F Radat C Creac'h E Guegan-Massardier, et al. 2008 Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria Headache 48 1026 1036 18081820
6. C Lundqvist K Aaseth RB Grande, et al. 2010 The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache Pain 148 487 491 20071079
7. D Dodick F Freitag 2006 Evidence-based understanding of medication-overuse headache: clinical implications Headache 46 Suppl 4 S202 S211 17078852
8. DW Dodick 2006 Clinical practice. Chronic daily headache N Engl J Med 354 158 165 1:CAS:528:DC%2BD28XisFWmtA%3D%3D 16407511 Published erratum appears in N Engl J Med 2006, 354:884
9. A Bahra M Walsh S Menon PJ Goadsby 2003 Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43 179 190 12603636
10. ME Bigal RB Lipton 2008 Excessive acute migraine medication use and migraine progression Neurology 71 1821 1828 1:CAS:528:DC%2BD1cXhtlylurjI 19029522 This article includes clinical evidence for medication-overuse headache
11. ME Bigal D Serrano D Buse, et al. 2008 Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study Headache 48 1157 1168 18808500
12. S Diamond ME Bigal S Silberstein, et al. 2007 Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study Headache 47 355 363 17371352 Published eratum appears in Headache 2007, 47:1365
13. V Limmroth Z Katsarava G Fritsche, et al. 2002 Features of medication overuse headache following overuse of different acute headache drugs Neurology 59 1011 1014 1:CAS:528:DC%2BD38XntFyit7s%3D 12370454
14. Z Katsarava HC Diener V Limmroth 2001 Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans Drug Saf 24 921 927 1:CAS:528:DC%2BD3MXptVyis74%3D 11735648
15. Z Katsarava G Fritsche M Muessig, et al. 2001 Clinical features of withdrawal headache following overuse of triptans and other headache drugs Neurology 57 1694 1698 1:CAS:528:DC%2BD38Xnsl0%3D 11706113
16. ME Bigal S Ashina R Burstein, et al. 2008 Prevalence and characteristics of allodynia in headache sufferers: a population study Neurology 70 1525 1533 1:STN:280:DC%2BD1c3mvVGmtQ%3D%3D 18427069
17. RB Lipton ME Bigal S Ashina, et al. 2008 Cutaneous allodynia in the migraine population Ann Neurol 63 148 158 18059010
18. R Burstein D Yarnitsky I Goor-Aryeh, et al. 2000 An association between migraine and cutaneous allodynia Ann Neurol 47 614 624 1:STN:280: DC%2BD3c3mtlSrsA%3D%3D 10805332
19. D Dodick S Silberstein 2006 Central sensitization theory of migraine: clinical implications Headache 46 Suppl 4 S182 S191 17078850
20. ME Bigal RB Lipton 2009 Excessive opioid use and the development of chronic migraine Pain 142 179 182 1:CAS:528:DC%2BD1MXjtF2jsLo%3D 19232469 This article includes clinical evidence for medication-overuse headache induced by opioids
21. EA Moulton R Burstein S Tully, et al. 2008 Interictal dysfunction of a brainstem descending modulatory center in migraine patients PLoS One 3 e3799 19030105 This article shows functional magnetic resonance imaging evidence of activation of nociceptive pathways associated with headache disorders
22. R Burstein MF Cutrer D Yarnitsky 2000 The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine Brain 123 Pt 8 1703 1709 10908199
23. R Burstein 2001 Deconstructing migraine headache into peripheral and central sensitization Pain 89 107 110 1:STN:280:DC%2BD3M3ksFCnsQ%3D%3D 11166465
24. RM Edelmayer TW Vanderah L Majuta, et al. 2009 Medullary pain facilitating neurons mediate allodynia in headache-related pain Ann Neurol 65 184 193 1:CAS:528:DC%2BD1MXktVynurc%3D 19259966 This article includes preclinical evidence of allodynia associated with dural stimulation as well as the requirement for activation of descending facilitation from the RVM for the expression of allodynia
25. ML Oshinsky S Gomonchareonsiri 2007 Episodic dural stimulation in awake rats: a model for recurrent headache Headache 47 1026 1036 17635594
26. AM Strassman SA Raymond R Burstein 1996 Sensitization of meningeal sensory neurons and the origin of headaches Nature 384 560 564 1:CAS:528:DyaK2sXhtlWh 8955268
27. R Burstein H Yamamura A Malick AM Strassman 1998 Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons J Neurophysiol 79 964 982 1:STN:280:DyaK1c7jtVKluw%3D%3D 9463456
28. H Yamamura A Malick NL Chamberlin R Burstein 1999 Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine J Neurophysiol 81 479 493 1:STN:280:DyaK1M7lvVygsw%3D%3D 10036252
29. F Porreca MH Ossipov GF Gebhart 2002 Chronic pain and medullary descending facilitation Trends Neurosci 25 319 325 1:CAS:528: DC%2BD38Xks1ymtLs%3D 12086751
30. LR Gardell R Wang SE Burgess, et al. 2002 Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers J Neurosci 22 6747 6755 1:CAS:528:DC%2BD38XlvFKnt7g%3D 12151554
31. CQ Meng S Rakhit DK Lee, et al. 2000 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine Bioorg Med Chem Lett 10 903 905 1:CAS:528:DC%2BD3cXjvVSjtLs%3D 10853656
32. M De Felice F Porreca 2009 Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache Cephalalgia 29 1277 1284 19438917 This article shows preclinical evidence of morphine-induced neuroadaptive changes in dural afferent of the trigeminal ganglia
33. A Okada-Ogawa F Porreca ID Meng 2009 Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons J Neurosci 29 15828 15835 1:CAS:528: DC%2BD1MXhs1Whur7P 20016098 This article demonstrates loss of DNIC in rats after exposure to chronic morphine
34. S Cathcart AH Winefield K Lushington P Rolan 2010 Noxious inhibition of temporal summation is impaired in chronic tension-type headache Headache 50 403 412 19817882
35. M de Tommaso M Sardaro C Pecoraro, et al. 2007 Effects of the remote C fibres stimulation induced by capsaicin on the blink reflex in chronic migraine Cephalalgia 27 881 890 17593297
36. •• Perrotta A, Serrao M, Sandrini G, et al.: Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalalgia 2010, 272-284. This article includes evidence of loss of DNIC in patients with MOH.
37. M De Felice MH Ossipov R Wang, et al. 2010 Triptan-induced latent sensitization: a possible basis for medication overuse headache Ann Neurol 67 325 337 20373344 This article shows preclinical evidence that repeated exposure to triptans lead to neuroadaptive changes that may be responsible for MOH
38. M De Felice MH Ossipov R Wang, et al. 2010 Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers Brain 133 2475 2488 20627971 These preclinical studies show potential clinical utility for nNOS inhibition in preventing or treating MOH
39. PJ Goadsby L Edvinsson R Ekman 1990 Vasoactive peptide release in the extracerebral circulation of humans during migraine headache Ann Neurol 28 183 187 1:STN:280:DyaK3M%2FisVSktQ%3D%3D 1699472
40. G Juhasz T Zsombok EA Modos, et al. 2003 NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release Pain 106 461 470 1:CAS:528:DC%2BD3sXptlyjs7k%3D 14659530
41. P Sarchielli A Alberti M Codini, et al. 2000 Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks Cephalalgia 20 907 918 1:STN:280: DC%2BD3MvntlSgsg%3D%3D 11304026
42. L Friberg J Olesen TS Olsen, et al. 1994 Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura Cephalalgia 14 47 54 1:STN:280:DyaK2c3lvVOjsw%3D%3D 7515329
43. X Zhang D Levy R Noseda, et al. 2010 Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura J Neurosci 30 8807 8814 1:CAS:528:DC%2BC3cXptFWgs78%3D 20592202 (Published erratum appears in J Neurosci 2010, 30:10259.) This article includes preclinical evidence that induction of CSD leads to long-lasting activation of the nociceptors that innervate the meninges, suggesting that migraine with aura is initiated by waves of CSD that lead to activation of the trigeminovascular pathway
44. W Supornsilpchai SM le Grand A Srikiatkhachorn 2010 Cortical hyperexcitability and mechanism of medication-overuse headache Cephalalgia 30 1101 1109 20713560 This article includes observations that MOH might be due to alteration of cortical excitability, which leads to an increased susceptibility of CSD development